Volume 19 - Issue 8 - August 2006
Yes. By Patrick A. DeHeer, DPM. While this author has had success with conservative treatment, particularly sclerosing therapy, he emphasizes that a plantar approach to the neurectomy can be effective when surgery is indicated.
Morton’s neuroma is a commonly encountered forefoot pathology that has many different treatment options available for the foot and ankle specialist. What are these options, when does one implement each type of treatment and when does surgical intervention become the best option for the patient?
Approximately 800,000 new cases of diabetes mellitus are diagnosed each year. The disease affects over 18 million people, approximately 6 percent of the population of the United States.1 Type 2 diabetes, which is typically not diagnosed in patients under age 45, is overwhelmingly the most prevalent of all types of diabetes as it affects nearly 17 million Americans.1 Symptoms of Type 2 diabetes are often not detected until they are severe or until patients seek treatment for related complications.2 Diabetes complications can result in blindness
The modern podiatric physician is faced with many challenges when it comes to appropriate patient selection for surgical procedures. Specifically, when it comes to the high-risk patient with diabetes, there are potential challenges that can lead to postoperative complications and potential lawsuits. Indeed, some of these high-risk patients may experience delayed wound healing with no obvious preoperative disease elucidated in the preoperative history, physical and conventional laboratory studies.
Faced with these challenges, the astute podiatric physician
Continuing Education »
For foot and ankle specialists, the diagnosis and complete management of neuropathic arthropathy ranks among the most daunting challenges. Currently, one makes the clinical diagnosis when there is a compilation of clinical and radiographic findings suspicious for the condition. The diagnosis relies upon the histopathology to identify the neuropathic joint destruction.
Once one makes a diagnosis, either definitively or clinically, the treatment approach remains the discretion of the physician. Those best trained for treating this condition rely on the lit
Perhaps your staff is battling an insurance company for appropriate reimbursement on a handful of claims. Perhaps you are wrestling with declining accounts receivable. Perhaps you are referring patients to other sources when you could be handling more of their DME needs. Perhaps you are debating whether you can afford to invest in new diagnostic technology for your practice.
Needless to say, office revenue affects nearly every aspect of maintaining and expanding a thriving practice. With this in mind, we turned to leading practitioners and practice mana
Editor's Perspective »
Imagine this scenario. A 75-year-old patient presents to a podiatric surgeon for treatment of a fracture of the fifth metatarsal base tuberosity. Instead of placing the patient in a walker, the podiatrist gives the patient crutches so he or she can see a CMS-approved durable medical equipment (DME) supplier in order to get the walker. The DPM just hopes the walker is correctly sized, modified when necessary and applied correctly.
Indeed, this may become the new reality as the Centers for Medicare and Medicaid Services (CMS) has proposed a competitive bi